Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Altman and Musk were OpenAI’s founding co-chairs in 2015, but their relationship has devolved into name-calling and lawsuits.
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Sam Altman's OpenAI launched ChatGPT Gov on Tuesday, which the company said government agencies could use to input sensitive ...